An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA
An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
Sponsor: Centrexion Therapeutics
A PHASE3 clinical study on Knee Osteoarthritis, this trial is completed. The trial is conducted by Centrexion Therapeutics and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
▶ Show 9 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE3
-
Oct 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Apr 2019 — Jun 2019 [monthly]
Recruiting PHASE3
-
Feb 2019 — Apr 2019 [monthly]
Recruiting PHASE3
-
Nov 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE3
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centrexion Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .